MedTrace Logo

EMDR vs Supportive Therapy in Relapse Prevention in Traumatized Bipolar Patients

NCT02634372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2022-12-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether EMDR (vs supportive therapy) is effective in relapse prevention over an observational period of 2 years in bipolar patients with a history of traumatic events.

Conditions

Interventions

BEHAVIORAL

EMDR therapy

EMDR: We designed a specific EMDR Bipolar Protocol which consists of a detailed interview with respect to traumatic events, the treatment of those with the EMDR standard protocol, and five new specific bipolar adapted EMDR protocols focusing on adherence, insight, de-idealisation of manic symptoms, prodromal symptoms and moodstabilization.

BEHAVIORAL

Supportive Therapy

Supportive therapy: Therapists adopt a client-centred focus, meaning that whatever problems the patient presents will be dealt with by providing emotional support and general advise. If no specific topic is mentioned by the patient, information about bipolar disorder and medication will be delivered by the therapist without referring to written or any other material.

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Hospital del Mar

    collaborator OTHER

  • Hospital Universitari de Bellvitge

    collaborator OTHER

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • Centro de Investigación Biomédica en Red de Salud Mental

    collaborator NETWORK

  • FIDMAG Germanes Hospitalàries

    lead OTHER

Principal Investigators

  • Benedikt L Amann, MD · Institut Hospital del Mar d'Investigacions Mèdiques

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02634372 on ClinicalTrials.gov